AssetMark Inc
TWST icon

AssetMark Inc’s Twist Bioscience TWST Stock Holding History

AssetMark Inc’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$206 Sell
2
-4
-67% -$260 ﹤0.01% 3423
2026
Q1 		$285 Hold
6
– – ﹤0.01% 3276
2025
Q4 		$190 Hold
6
– – ﹤0.01% 3262
2025
Q3 		$169 Sell
6
-3
-33% -$91 ﹤0.01% 3087
2025
Q2 		$331 Buy
+9
New +$311 ﹤0.01% 2808
2024
Q3 		– Sell
-3
Closed -$148 – 2362
2024
Q2 		$148 Buy
+3
New +$122 ﹤0.01% 2023
2022
Q4 		– Sell
-32
Closed -$1K – 1661
2022
Q3 		$1K Hold
32
– – ﹤0.01% 1487
2022
Q2 		$1K Hold
32
– – ﹤0.01% 1451
2022
Q1 		$2K Sell
32
-8,799
-100% -$488K ﹤0.01% 1444
2021
Q4 		$683K Buy
+8,831
New +$906K ﹤0.01% 489

Other funds holding TWST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

AssetMark Inc's TWST Position: Q2 2026 in Review

AssetMark Inc reduced its Twist Bioscience (TWST) stake by 67% in Q2 2026, selling an estimated $260 and leaving 2 shares worth $206. The position accounts for ﹤0.01% of the portfolio, ranked #3423.

AssetMark Inc first reported a position in TWST in Q4 2021 and has held it in 10 quarters since. The position peaked at $683K in Q4 2021. 337 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

  • AssetMark Inc held 2 shares of Twist Bioscience worth $206 as of Q2 2026.
  • AssetMark Inc sold 4 Twist Bioscience shares in Q2 2026, an estimated $260.
  • Twist Bioscience made up ﹤0.01% of AssetMark Inc's portfolio in Q2 2026, its #3423 holding.
  • AssetMark Inc first reported a position in Twist Bioscience in Q4 2021 and has held it in 10 quarters since.
  • AssetMark Inc's Twist Bioscience position peaked at $683K in Q4 2021.
  • 337 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on AssetMark Inc's 13F filing for Q2 2026, filed 30 Jul 2026.